• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性大疱性表皮松解症:新的诊断方法和新的临床表型。

Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes.

机构信息

Faculty of Medicine, Department of Dermatology, Medical Center, University of Freiburg, University of Freiburg, Freiburg, Germany.

Faculty of Medicine, Department of Human Genetics, Medical Center, University of Freiburg, University of Freiburg, Freiburg, Germany.

出版信息

Exp Dermatol. 2019 Oct;28(10):1146-1152. doi: 10.1111/exd.13668. Epub 2018 Jun 28.

DOI:10.1111/exd.13668
PMID:29679399
Abstract

Inherited epidermolysis bullosa (EB) is a group of heterogeneous genetic disorders characterized by skin fragility. EB comprises a large spectrum of phenotypes, ranging from severe cutaneous and extracutaneous involvement caused by lack of key adhesion proteins, to mild cutaneous fragility caused by subtle molecular defects. Disease-causing variants in 20 different genes account for the genetic and allelic heterogeneity of EB. Here, we discuss the development of laboratory methods that enabled these discoveries and the clinical and molecular features of some new EB entities elucidated during the past 5-6 years.

摘要

遗传性大疱性表皮松解症(EB)是一组以皮肤脆弱为特征的异质性遗传疾病。EB 包括一系列表型,从由于关键黏附蛋白缺失导致的严重皮肤和皮肤外受累,到由于细微分子缺陷导致的轻度皮肤脆弱。20 个不同基因的致病变异导致了 EB 的遗传和等位基因异质性。在这里,我们讨论了使这些发现成为可能的实验室方法的发展,以及在过去 5-6 年内阐明的一些新的 EB 实体的临床和分子特征。

相似文献

1
Inherited epidermolysis bullosa: New diagnostics and new clinical phenotypes.遗传性大疱性表皮松解症:新的诊断方法和新的临床表型。
Exp Dermatol. 2019 Oct;28(10):1146-1152. doi: 10.1111/exd.13668. Epub 2018 Jun 28.
2
Inherited epidermolysis bullosa: new diagnostic criteria and classification.遗传性大疱性表皮松解症:新的诊断标准和分类。
Clin Dermatol. 2012 Jan-Feb;30(1):70-7. doi: 10.1016/j.clindermatol.2011.03.012.
3
Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes.大疱性表皮松解症的半桥粒变体。α6β4整合素和180-kD类天疱疮抗原/ XVII型胶原蛋白基因中的突变。
Exp Dermatol. 1998 Apr-Jun;7(2-3):46-64. doi: 10.1111/j.1600-0625.1998.tb00304.x.
4
Clinical subtypes and molecular basis of epidermolysis bullosa in Kuwait.科威特的大疱性表皮松解症的临床亚型和分子基础。
Int J Dermatol. 2018 Sep;57(9):1058-1067. doi: 10.1111/ijd.14099. Epub 2018 Jul 16.
5
Mutation analysis and molecular genetics of epidermolysis bullosa.大疱性表皮松解症的突变分析与分子遗传学
Matrix Biol. 1999 Feb;18(1):29-42. doi: 10.1016/s0945-053x(98)00005-5.
6
Homozygous ITGA3 Missense Mutation in Adults in a Family with Syndromic Epidermolysis Bullosa (ILNEB) without Pulmonary Involvement.一个患有综合征性大疱性表皮松解症(ILNEB)且无肺部受累的家族中成人的纯合子ITGA3错义突变。
J Invest Dermatol. 2021 Nov;141(11):2752-2756. doi: 10.1016/j.jid.2021.03.029. Epub 2021 May 21.
7
Progress in epidermolysis bullosa: genetic classification and clinical implications.大疱性表皮松解症的进展:遗传分类及临床意义
Am J Med Genet C Semin Med Genet. 2004 Nov 15;131C(1):61-74. doi: 10.1002/ajmg.c.30035.
8
Identification and Computational Analysis of Novel Pathogenic Variants in Pakistani Families with Diverse Epidermolysis Bullosa Phenotypes.巴基斯坦具有不同表型的大疱性表皮松解症家系中新型致病性变异的鉴定和计算分析。
Biomolecules. 2021 Apr 22;11(5):620. doi: 10.3390/biom11050620.
9
Genetic diagnosis of epidermolysis bullosa: recommendations from an expert Spanish research group.大疱性表皮松解症的基因诊断:西班牙一个专家研究小组的建议
Actas Dermosifiliogr (Engl Ed). 2018 Mar;109(2):104-122. doi: 10.1016/j.ad.2017.08.008. Epub 2017 Nov 26.
10
Novel compound heterozygous mutations in the PLEC gene in a neonate with epidermolysis bullosa simplex with pyloric atresia.一名患有单纯性大疱性表皮松解症合并幽门闭锁的新生儿中PLEC基因的新型复合杂合突变。
J Dermatol. 2023 Feb;50(2):239-244. doi: 10.1111/1346-8138.16553. Epub 2022 Aug 23.

引用本文的文献

1
Consensus statements for the transdisciplinary care of patients with epidermolysis bullosa in South Africa: Part 1.南非大疱性表皮松解症患者跨学科护理的共识声明:第1部分。
Health SA. 2025 Aug 6;30:2963. doi: 10.4102/hsag.v30i0.2963. eCollection 2025.
2
The health-related quality of life of Brazilians with epidermolysis bullosa.患有大疱性表皮松解症的巴西人的健康相关生活质量。
Orphanet J Rare Dis. 2025 Jul 4;20(1):341. doi: 10.1186/s13023-025-03753-w.
3
Intermediate filaments and their associated molecules.中间丝及其相关分子。
J Biomed Res. 2025 Feb 8;39(3):242-253. doi: 10.7555/JBR.38.20240193.
4
Integrin mutations in blistering skin diseases and related genetically engineered mouse models.大疱性皮肤病中的整合素突变及相关基因工程小鼠模型
Hum Immunol. 2024 Nov;85(6):111175. doi: 10.1016/j.humimm.2024.111175. Epub 2024 Nov 11.
5
Syndromic epidermolysis bullosa simplex subtype due to mutations in the gene: series of case reports in Russian families.由于该基因发生突变导致的综合征型单纯性大疱性表皮松解症亚型:俄罗斯家族中的系列病例报告
Front Med (Lausanne). 2024 Jul 29;11:1418239. doi: 10.3389/fmed.2024.1418239. eCollection 2024.
6
Identification of Pathogenic Pathways for Recurrence of Focal Segmental Glomerulosclerosis after Kidney Transplantation.肾移植后局灶节段性肾小球硬化复发的致病途径鉴定
Diagnostics (Basel). 2024 Jul 24;14(15):1591. doi: 10.3390/diagnostics14151591.
7
Skin Microbial Composition and Genetic Mutation Analysis in Precision Medicine for Epidermolysis Bullosa.大疱性表皮松解症精准医学中的皮肤微生物组成与基因突变分析
Curr Drug Targets. 2024;25(6):404-415. doi: 10.2174/0113894501290512240327091531.
8
Roles for epithelial integrin α3β1 in regulation of the microenvironment during normal and pathological tissue remodeling.上皮细胞整合素 α3β1 在正常和病理性组织重塑过程中对微环境的调节作用。
Am J Physiol Cell Physiol. 2024 May 1;326(5):C1308-C1319. doi: 10.1152/ajpcell.00128.2024. Epub 2024 Mar 18.
9
Independent Variants in Cats with Junctional Epidermolysis Bullosa.患有交界性大疱性表皮松解症的猫中的独立变异。
Genes (Basel). 2023 Sep 22;14(10):1835. doi: 10.3390/genes14101835.
10
Organization, dynamics and mechanoregulation of integrin-mediated cell-ECM adhesions.整合素介導的細胞-細胞外基質黏附的組織、動態和機械調節。
Nat Rev Mol Cell Biol. 2023 Feb;24(2):142-161. doi: 10.1038/s41580-022-00531-5. Epub 2022 Sep 27.